SecBot SecBot
S-1/A ·Filed Jul 16, 2026

ISPC

iSpecimen Inc.
BEARISH
Impact 7/10
Horizonweeks Processed3mo ago SEC0001213900-26-078869
IPO registration amendment
Actionable Insight ▼ Bearish

The offering is highly dilutive and the company faces severe revenue decline and a going concern. Monitor the pace of cash burn and whether the full $5M is raised; if less, the company may need additional capital within months. The pre-paid $2M marketing contract with IR Agency is a cash outflow with no guaranteed return. Traders should expect continued volatility and potential delisting risk if the stock price falls below $1.00 again.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ISPC ▼ -48.57% at T+60d
SHORT call ✓ call won +48.57% · α vs SPY +53.25% · entry $2.10 → $1.08
Entry = T+0 close
Jul 16, 2026
via day close
T+1d
+10.48%
call -10.48% · α -10.64%
$2.32
settled 3mo ago
T+5d
+6.19%
call -6.19% · α -6.88%
$2.23
settled 3mo ago
T+20d
+7.14%
call -7.14% · α -2.70%
$2.25
settled 3mo ago
T+60d
-48.57%
call +48.57% · α +53.25%
$1.08
settled 18d ago

Executive Summary

iSpecimen filed Amendment No. 2 to its S-1 registration statement, increasing the maximum offering from $4M to $5M (up to 2,092,050 shares at $2.39/sh) on a best-efforts basis with no minimum. The company has a going concern opinion, negative working capital, and a 79% YoY revenue decline in FY2025 to $1.9M. Proceeds of up to $4.68M (net) are earmarked for marketing, potential acquisitions, and working capital, with $2M pre-paid to IR Agency LLC for three months of services. The offering is highly dilutive at ~167% of the current $3M market cap, and the company's deteriorating fundamentals make this a distressed capital raise.

Key Financial Metrics

Price Range
$2.39 per share (assumed, based on July 14, 2026 closing price; final price to be negotiated)
Rev Growth
-79.2%

Key Facts

  • Offering size increased to $5M (up to 2,092,050 shares) at assumed $2.39/sh, best-efforts with no minimum; net proceeds ~$4.68M if fully sold.
  • FY2025 revenue fell 79% to $1,928,998 from $9,291,115 in FY2024; Q1 2026 revenue down 85% YoY to $156,009.
  • Net loss was $10.5M in FY2025, $2.3M in Q1 2026; accumulated deficit of $84.6M as of March 31, 2026.
  • Cash $2.8M, working capital deficit of $2.1M; auditors included going concern qualification.
  • Material weakness in internal control over sales tax reporting identified in FY2025.
  • $2M consulting agreement with IR Agency LLC for marketing services, prepaid on closing; plus up to $1.1M in additional marketing from proceeds.
  • Common stock outstanding pre-offering: 1,522,359 shares; post-offering up to 3,614,409 shares (137% dilution).
  • Nasdaq bid price compliance regained in May 2026 after a 1-for-40 reverse split in April 2026.

Financial Impact

Up to $5M gross proceeds (167% of current $3M market cap) with net ~$4.68M; significant dilution for existing holders.

revenuenet losscashworking capitalshare countenterprise value

Risk Factors

  • Best-efforts offering with no minimum — may raise substantially less than $5M, accelerating cash runway depletion.
  • Revenue is non-recurring, highly concentrated (one customer = 54% of Q1 2026 revenue), and declining sharply.
  • Going concern with $2.8M cash and negative working capital; future capital needs are uncertain.
  • Material weakness in internal controls over sales tax could lead to restatements or penalties.
  • Pre-paid $2M marketing fee with no performance guarantee reduces flexibility; IR Agency has no securities licenses.
  • Nasdaq delisting risk remains if bid price < $1.00 again; reverse split history shows structural fragility.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001213900-26-078869
Document: ea029813601ex10-47.htm0001213900-26-078869
Document: ea029813601ex-fee.htm0001213900-26-078869
Document: ea029813601ex5-1.htm0001213900-26-078869
Document: ea029813601ex23-1.htm0001213900-26-078869
Document: 0001213900-26-078869-index-headers.html0001213900-26-078869
Document: 0001213900-26-078869-index.html0001213900-26-078869
Document: 0001213900-26-078869.txt0001213900-26-078869
16 reports for ISPC
Performance horizon
86% Hit rate @ T+60 6 of 7 directional calls Went positive at some point 11 of 11 best @ T+60▲ +61.98%May 8, 2026
Filters
Rows
Reports for ISPC — sortable, filterable
TypeNow
Sep 10, 2026
6w ago
8-K
BEARISH ★ 8/10
$1.47awaiting T+60—$0.8170 (+44.42%)
Sep 4, 2026
7w ago
8-K
NEUTRAL ★ 6/10
$1.59awaiting T+60—$0.8170 (−48.62%)
Aug 14, 2026
10w ago
8-K
BEARISH ★ 7/10
$2.15awaiting T+60—$0.8170 (+62.00%)
Aug 7, 2026
11w ago
8-K
BEARISH ★ 7/10
$2.24awaiting T+60—$0.8170 (+63.53%)
Aug 7, 2026
11w ago
424B4
BEARISH ★ 7/10
$2.22awaiting T+60—$0.8170 (+63.20%)
Jul 31, 2026
12w ago
EFFECT
BEARISH ★ 7/10
$1.89 $0.8398▲ +55.57%▲ +58.02%$0.8170 (+56.77%)
Jul 16, 2026
14w ago
S-1/A
BEARISH ★ 7/10
$2.10 $1.08▲ +48.57%▲ +53.25%$0.8170 (+61.10%)
Jul 14, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$2.23 $1.09▼ −51.12%▼ −53.65%$0.8170 (−63.36%)
Jun 18, 2026
18w ago
EFFECT
BEARISH ★ 7/10
$2.59 $1.47▲ +43.24%▲ +45.14%$0.8170 (+68.46%)
Jun 1, 2026
21w ago
8-K
BEARISH ★ 7/10
$3.07 $1.64▲ +46.58%▲ +47.70%$0.8170 (+73.39%)
Showing 10 of 16

US Market Status

Market Closed — Opens Wed (13h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 17, 2026